Stylus Medicine
Stylus Medicine is a biotechnology company focused on developing transformative in vivo genetic medicines. The company leverages therapeutic-grade recombinases and lipid nanoparticle delivery to precisely encode therapeutic payloads, starting with in vivo CAR-Ts. Their goal is to bring the promise of genetic medicines to every patient in need.
Funding Round: Series A+
Funding Amount: $85M
Date: 13-May-2025
Investors: RA Capital Management, Khosla Ventures, Chugai Venture Fund, Eli Lilly and Company, Johnson & Johnson Innovation – JJDC
Markets: Biotechnology, Gene Therapy, Oncology
HQ: Cambridge, Massachusetts, United States
Founded: 2022
Website: https://www.stylusmedicine.com
LinkedIn: https://www.linkedin.com/company/stylus-medicine/
Twitter: https://twitter.com/stylus_medicine
Crunchbase: https://www.crunchbase.com/organization/stylus-medicine
Leave a Comment
Comments
No comments yet.